Mark C. Schneyer

EVP, Chief Financial Officer, Acadia Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$1.1M

Companies

Latest trade

Aug 6, 2026

Companies

Acadia PharmaceuticalsEVP, Chief Financial Officer −$1.1M

Trades

ACAD Sold 14,292 shares at $29.22 · planned $0.4M Aug 6

ACAD Sold 5,849 shares at $29.00 · planned $0.2M Aug 5

ACAD Sold 3,506 shares at $21.79 · planned $0.1M May 4

ACAD Sold 2,709 shares at $22.20 · planned $0.1M Apr 7

ACAD Sold 3,208 shares at $21.65 · planned $0.1M Mar 26

ACAD Sold 4,177 shares at $21.47 · planned $0.1M Mar 25

ACAD Sold 10,262 shares at $23.69 · planned $0.2M Nov 18

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.